Trials Annotator

Trial NCT00023244

Org. Study IDs: DAIT SW01

Last trial update was posted on 2016-10-21

MeSH Interventions

Basiliximab Cyclosporine Cyclosporins Methylprednisolone Prednisone Sirolimus Sulfamethoxazole Tacrolimus Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination

MeSH Conditions

Kidney Failure, Chronic

Other Conditions

End-Stage Renal Disease

Stopping Reasons

Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative disorder

Limitations And Caveats

N/A

Result Publications

Benfield MR, Bartosh S, Ikle D, Warshaw B, Bridges N, Morrison Y, Harmon W. A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant. 2010 Jan;10(1):81-8. doi: 10.1111/j.1600-6143.2009.02767.x. Epub 2009 Jul 28. [PMID: 19663893] [DOI: 10.1111/j.1600-6143.2009.02767.x]
McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, Wyatt R, Arar M, Liereman D, Bridges N, Harmon W; CCTPT Study Group. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant. 2008 May;8(5):984-9. doi: 10.1111/j.1600-6143.2008.02167.x. [PMID: 18416737] [DOI: 10.1111/j.1600-6143.2008.02167.x]

Annotations

Category Annotations

No annotators decided on categories yet

Intervention Annotations

#	Outdated	Intervention				Condition
#	Outdated	Name		Route	DrugBank ID	Condition